Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Change in Taxes (2022 - 2025)

Sunshine Biopharma (SBFM) has disclosed Change in Taxes for 4 consecutive years, with $162992.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Taxes fell 68.66% year-over-year to $162992.0, compared with a TTM value of $68422.0 through Sep 2025, down 75.85%, and an annual FY2024 reading of -$812080.0, down 1008.69% over the prior year.
  • Change in Taxes was $162992.0 for Q3 2025 at Sunshine Biopharma, up from $30043.0 in the prior quarter.
  • Across five years, Change in Taxes topped out at $1.0 million in Q4 2023 and bottomed at -$1.2 million in Q2 2024.
  • Average Change in Taxes over 4 years is -$41147.8, with a median of -$5059.0 recorded in 2025.
  • The sharpest move saw Change in Taxes soared 323.55% in 2023, then plummeted 530.84% in 2024.
  • Year by year, Change in Taxes stood at $238679.0 in 2022, then skyrocketed by 323.55% to $1.0 million in 2023, then plummeted by 108.35% to -$84452.0 in 2024, then soared by 293.0% to $162992.0 in 2025.
  • Business Quant data shows Change in Taxes for SBFM at $162992.0 in Q3 2025, $30043.0 in Q2 2025, and -$40161.0 in Q1 2025.